The face is the most exposed part of our body, and deterioration of facial appearance,
through disease or ageing, causes psychological distress. Acne lesions and subsequent …

Background: Two hormonal agents with contraceptive properties are currently indicated in
Canada for treatment of acne. Objective: The purpose of this study was to determine the …

BACKGROUND: This open-label, noncontrolled study assessed the long-term efficacy and
tolerability of the monophasic combined low-dose oral contraceptive (OC) ethinyl estradiol …

Abstract Background and Objective: It is generally accepted that the inhibition of sebum
excretion has a predictive value for anti-acne activity. Whereas oral 13-cis-retinoic acid (13 …

Background: Acne vulgaris is a chronic disease with a multifactorial pathogenesis.
Speculative data has been shown concerning acne vulgaris and hormones, obesity …

The aim of this open, noncontrolled phase III study was the assessment of the contraceptive
efficacy and the evaluation of the safety of long-term use of Belara®(30 μg ethinyl estradiol …

Androgens playa well-recognized, central role in the pathogenesis of acne. Androgens
promote the maturation of the sebaceous glands and sebum secretion that are essential for …

Oral contraceptives (OCs) have been shown to be safe and effective for the treatment of
acne in most women of childbearing potential, and several have been approved by the Food …

Desogestrel is a highly selective gonane progestin. A monophasic formulation containing
150 of μg desogestrel and 30 μg of ethinyl estradiol has recently been approved as an oral …

BACKGROUND: A randomized, double-blind, parallel-group study to investigate the efficacy
and safety of the 3 mg drospirenone (drsp)/20 mcg ethinylestradiol (EE) combined oral …